COO of Atricure Inc (30-Year Financial, Insider Trades) Douglas J Seith (insider trades) sold 31,440 shares of ATRC on 12/26/2019 at an average price of $32 a share. The total sale was $1 million.
AtriCure Inc is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, scars in cardiac, heart, and tissue. It generates revenue by selling disposable surgical devices. AtriCure Inc has a market cap of $1.27 billion; its shares were traded at around $32.04 with and P/S ratio of 5.36. AtriCure Inc had annual average EBITDA growth of 8.30% over the past five years. GuruFocus has detected 1 severe warning sign with AtriCure Inc. .
CFO Recent Trades:
- SVP and CFO M. Andrew Wade sold 1,000 shares of ATRC stock on 12/26/2019 at the average price of $32. The price of the stock has increased by 0.13% since.
Directors and Officers Recent Trades:
- COO Douglas J Seith sold 31,440 shares of ATRC stock on 12/26/2019 at the average price of $32. The price of the stock has increased by 0.13% since.
For the complete insider trading history of ATRC, click here
.
